chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine give at 6:07pm,  6:21pm patient complaining she was sweating and was hot. I got a ice pack out of the freezer and gave it to her.   she said she couldn't see.  She was having tunnel vision.  she said she could not see and could not hear.  She had to go to the bathroom.  Person in charge up front called the EMTs and brought a wheelchair cart to pharmacy to take her to bathroom.  EMTs came and checked her vitals .  She refused to go to hospital.  EMT left at 6:39pm t
I had contracted COVID-19 and tested positive on Valentine's Day, 02/14/2023. I contacted my doctor the next morning and was prescribed Paxlovid for treatment and began the regime that same day.  After a couple of days of treatment, I'm doing much better with no residual symptoms.
This medically confirmed spontaneous report received by a sales representative (initial receipt 29-May-2014) concerns a female patient. On an unspecified date, the patient received a influenza virus vaccine (manufacturer and batch number not reported) and PNEUMOVAX 23 injection (batch number not reported). On an unspecified date after receiving the vaccine, the patient was found unconscious and rushed to the emergency room. The patient was admitted in an unspecified hospital, on an unspecified date for an unspecified length of time. Outcome was not reported.
pt recv vax 16NOV95 & 3JUL96 2wk p/exposure to active varicella pt devel 10 to 20 varicella like lesions which never blistered;
diarrhea; Neck hurts; Pains/ache; headache; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), DIARRHOEA (diarrhea), NECK PAIN (Neck hurts), MYALGIA (Pains/ache) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 21B51A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), MYALGIA (Pains/ache) and HEADACHE (headache). On 31-Mar-2021, the patient experienced DIARRHOEA (diarrhea) and NECK PAIN (Neck hurts). At the time of the report, OROPHARYNGEAL PAIN (sore throat), DIARRHOEA (diarrhea) and NECK PAIN (Neck hurts) outcome was unknown, MYALGIA (Pains/ache) had resolved and HEADACHE (headache) had not resolved. Not Provided          No concomitant and treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-065232 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065232:Cross-linked with first dose
she tested positive with COVID-19; This is a spontaneous report from a contactable consumer (Patient) from a Pfizer Sponsored Program COVAX US Support. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No medical information was reported. On 29Mar2021, the patient reported that she tested positive with COVID-19. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Student c/o paresthesias and coldness L arm and fingers after vaccine. No localized reaction @ injection site. Good ROM BUE, grip strength + and equal bilat., CRT brisk.
Sore throat, ear pain, runny nose. Sick about week and half after shot.
it was reported that patient experienced: Severe swelling in feet and leg; rapid heartbeat; extreme exhaustion; flare-ups all over body; This is a spontaneous report from Drug Safety and consumer (patient): A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date were not reported) via unspecified route of administration on an unknown date at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included tocilizumab (ACTEMRA). On 01May2021, it was reported that patient experienced: severe swelling in feet and legs, rapid heartbeat, extreme exhaustion, flare-ups all over body. The outcome of the reported events was unknown.  No further information was reported.Information about lot/batch number has been requested.
Patient c/o the "typical" soreness the next day after receiving the vaccine, but it "carried on" for quite some time.  She describes the pain as deep inside her right shoulder which made shoulder movement difficult.  Pain was mild at rest but with movement "5" severity on 1/10 scale.  This intensity lasted for about 3 weeks then gradually resolved about 2 months later.  Slight swelling, no noticable redness.  She called her physician but he was not available, so she did not discuss sx with him nor was she seen by her physician.  She used warm & cool compresses for the discomfort and rest as treatment.  She reports that she had been in a car accident 2 weeks before getting the vaccine but had no shoulder pain associated with the car accident (pain did not start until day following vaccine).
No further adverse effect reported; patient received a dose of improperly stored ROTATEQ; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. The patient's pertinent concurrent conditions, medical history, concomitant medications and previous drugs reactions or allergies were not provided.  On 20-FEB-2020, the patient was vaccinated with a improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 1 dose as prophylaxis (concentration, number of administered dose, vaccination scheme frequency, route and anatomical location of vaccination were not reported; lot number  S014947 has been verified to be a valid, expiration date reported and validated as 10-DEC-2020). No adverse effects were reported for the patient  According to the reporter, the temperature excursion was 36 degrees Fahrenheit (34 degrees Fahrenheit) for a time frame of 27 minutes on an unspecified date (product storage error), without any previous temperature excursion; which was detected by a digital data logger.; Sender's Comments:  US-009507513-2002USA009991:
1. Mild Icthy on the Skin [Face other party of body] - Took Benadryl  - Night of vaccine day 2. Face Swollen [ Lymph node]  - Next day of vaccine day 3. Neck Swollen - Next day of vaccine day 4. Fatigue  - After 2 days  5. Pain in the lower abodmen. 6. Feeling like increase in weight or Puffiness in the mody.
2 people in another country had the same issues (vision issues); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (2 people in another country had the same issues (vision issues)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISUAL IMPAIRMENT (2 people in another country had the same issues (vision issues)). At the time of the report, VISUAL IMPAIRMENT (2 people in another country had the same issues (vision issues)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
flushing of face and chest, slightly swollen tongue, extreme thirst, difficulty breathing (when not through nose), felt very hot, then felt very cold (had chills), felt "off" per patient. Asked me to call ambulance.
3 months after receiving vaccines child developed balance issues, would not walk, sleeping more, appetite decreased.
pt to hospital with SOB, malaise, poor oral intake, myalgias x 3 days; positive test for COVID in hospital; Decadron; worsening confusion; AF with RVR, treated with  medication; multiorgan failure; DNR; pt passed away in the hospital
Provider administered the Pedi COVID vaccine (5-11).  This patient received the first the COVID (12+) vaccine on 11-21-21.
symptoms left lower leg pain one day after receiving 2nd COVID vaccine, diagnosed with left leg DVT 13 March
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patient's current conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with unspecified doses of improperly stored ROTATEQ, oral (unknown strength). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events was unknown. There was not product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Ringing in ears; Nausea; Heart palpitations; heart rate elevated to 163; This is a spontaneous report from a contactable nurse (patient herself). A 39-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiry date not reported), via an unspecified route of administration in the right arm on 07Jan2021 12:30 at single dose for COVID-19 immunisation. Medical history included asthma. The patient was not pregnant. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT), levothyroxine sodium (SYNTHROID), montelukast sodium (SINGULAIR), and paracetamol (TYLENOL). The patient previously took first dose of bnt162b2 (lot number: EH9899, expiry date not reported) in the left arm on 17Dec2020 at 12:30 at single dose for COVID-19 immunisation. The patient previously took amoxicillin and experienced allergies. On 07Jan2021 16:45, the patient experienced ringing in ears, nausea, heart palpitations, and heart rate elevated to 163. Clinical outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
feeling numbness in roof of mouth; feeling numbness in lips; feeling numbness in tounge; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (feeling numbness in roof of mouth), HYPOAESTHESIA ORAL (feeling numbness in lips) and HYPOAESTHESIA ORAL (feeling numbness in tounge) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced HYPOAESTHESIA ORAL (feeling numbness in roof of mouth), HYPOAESTHESIA ORAL (feeling numbness in lips) and HYPOAESTHESIA ORAL (feeling numbness in tounge). At the time of the report, HYPOAESTHESIA ORAL (feeling numbness in roof of mouth), HYPOAESTHESIA ORAL (feeling numbness in lips) and HYPOAESTHESIA ORAL (feeling numbness in tounge) outcome was unknown.            Concomitant medications were not provided.   This case was linked to MOD-2021-047443 (Patient Link).
Message sent from to patient to Doctor's office: From: To:  Sent: 10/8/2020  3:38 PM MDT Subject: Other: Specify Below  Vaccine Poor Reaction. Dr. : FYI  after my pneumococcal 23 vaccine on Monday (10-5-20), I had to go to bed until 10 a.m. next day. Had a fever, felt very tired, had a red rash at the left arm injection site and  couldn't move that arm much for a couple of days. Had a fever up to 102.5 then it would drop and it was up and down all day Monday but returned to normal thereafter. I have never had a vaccine reaction before-- but I do seem to have a lower tolerance to drugs now than when younger. Didn't have a problem after flu vaccine last year. Just wanted you to know what happened. I seem ok now.
Within days of 2nd vaccine: Pain at the site, fever, chills, soreness, exhaustion, mental fatigue, swollen lymph nodes.  Within weeks of vaccination: depressive symptoms including lack of motivation .
Patient complained of itchiness right away and then later in the day had pain in her arm down to her fingers. patient took 2 Benadryl to help with the itching.
No averse event; HCP called to report T/E for GARDASIL 9. HCP stated 2 patients inadvertently patient received GARDASIL 9 during the T/E.   GARDASIL 9 was administered on 10/31/2023 and it was the 1st dose for the patient.  AE case filed # 02508287.  No other informa; This spontaneous report was received from a nurse refers to a female patient of unknown age.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 31-OCT-2023, the patient was vaccinated with the first improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot #1957405, expiration date: 11-NOV-2025 (exact dose, route of administration and anatomical location were not reported) for prophylaxis.    On 26-OCT-2023 and 27-OCT-2023, administered dose of vaccine was exposed to the temperature excursion of -2.04 degrees Celsius for 2 hours, -1.61 degrees Celsius for 1 hour and 30 minutes, -1.56 degrees Celsius for 45 minutes, -1.04 degrees Celsius for 30 minutes, -0.82 degrees Celsius for 1 hour and 15 minutes, -1.21 degrees Celsius for 1 hour and 15 minutes (product storage error). There were no additional adverse events reported (no adverse event).
presented to the emergency room with complaints of fever of 102;  left lower lobe COVID-19 PNA. He was treated with IV Decadron,  empiric antibiotics, oxygen therapy and was seen by an ID specialist and his inflammatory markers being monitored. He was also seen by oncology since he had CLL. His shortness of breath gradually improved, he continued to require oxygen. He remained stable and was later discharged home on oral steroids and home oxygen.
7 inches of swelling around injection site (especially surrounding bicep), redness, appearance of one large hive, hot to the touch, painful both when you touch the area and when resting (not touching), difficulty lifting arm higher than shoulder, nausea
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age. On 29-OCT-2012, the patient was inadvertently vaccinated with an expired dose of GARDASIL (lot # 0992Z; exp. date: 14-OCT-2012) (dose and route not reported). No adverse effects reported. Additional information is not expected.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age. Starting from 06-AUG-2015, the patients were inadvertently vaccinated with an improperly stored dose of RECOMBIVAX HB lot #K006682, expiry date 17-DEC-2015, J004700, expiry date 26-NOV-2015, K020126, expiry date 17-SEP-2016. No adverse reactions were reported. The outcome of the events were unknown. This is one of the 4 linked cases reported by the same reporter. Additional information has been requested.
After sitting  for about 10 minutes, I noticed my tongue was swelling up in the back of my throat. I noticed my airway was narrowed and tongue felt very tight, but I was still able to breath. I told the man at the doorway assigned to help people find a seat after their shots. He said, "We all have different reactions," brought me water, and I drank it.  After another 10 minutes, the symptoms were the same, not better not worse. After 10 more minutes the symptoms were better. And after another 10 minutes, I left.  When I made it back to my car, I noticed tightening across my forehead. This developed into a frontal lobe headache which continued off and on for the next 3 days. Also noted for the next 2 days was waking with swollen lips, face and extremities, and occasional ringing in the ears lasting 1-2 hours.
This case was reported by a nurse via sales rep and described the occurrence of adverse event in a adult patient who received FLULAVAL QUADRIVALENT for prophylaxis. On an unknown date, the patient received FLULAVAL QUADRIVALENT at an unknown dose. On an unknown date, unknown after receiving FLULAVAL QUADRIVALENT, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to FLULAVAL QUADRIVALENT. Additional details reported as follows: The age at vaccination was not reported. The patient complained (unspecified reaction) after vaccination with FLULAVAL QUADRIVALENT. This case has been linked with case US2018GSK173210 and US2018GSK173218, reported by same reporter.
This spontaneous report as received from a other healthcare worker and refers to three patients of unknown age or gender. The patient's concurrent condition, medical history and concomitant therapy were not provided. On an unknown dates, one unspecified patient was vaccinated with a dose of improperly stored ROTATEQ, lot # M018958, expiration date: 03-MAR-2018 and two unspecified patients were vaccinated with improperly stored doses of VAQTA, lot # M032492, expiration date: 02-MAR-2018 (dose and route were unknown) for prophylaxis.  No adverse effects reported. The temperature for the vaccines stored was 0 degrees Celsius to 1 degree Celsius, with 5 hours time frame. Previous temperature excursion was not reported. Data logger was not involved. Additional information has been requested.
Her arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm was sore) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included No adverse effect (Medical History not provided).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Her arm was sore). At the time of the report, PAIN IN EXTREMITY (Her arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for this event was not provided with the exception of the two naproxen taken by the patient. Her inquiry was to whether or not she could rub the hand with rubbing alcohol as it was still very sore.  Company Comment: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
This case was reported by a other health professional via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the vaccine coordinator. The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. This case has been linked to US2018GSK111891 and US2018GSK111892, reported by the same reporter.
After my first Covid vaccine on Jan 11 I began to experience some pain and stiffness in my left hand.    In particular it was kind of cramped up and stiff when I woke up in the morning.   Two days after my second Covid vaccine on Feb 8,   those symptoms became much worse.   My hand was very stiff in the morning and I couldn't straighten my index finger except by pulling it up with my other hand.  Prior to receiving the Covid vaccines, I had never experienced these issues before.
Patient came in on 11/1 complaining of arm hurting and all red day after (Friday 10/29) booster Moderna dose.  She went to the doctor on Monday 11/1 and he said that the arm was infected and he prescribed her an antibiotic (Bactrim DS).
Warmer than the normal part; Red welt where I had the shot; itchy a little bit; red arm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmer than the normal part), VACCINATION SITE URTICARIA (Red welt where I had the shot), VACCINATION SITE PRURITUS (itchy a little bit), VACCINATION SITE PAIN (Arm was sore) and VACCINATION SITE ERYTHEMA (red arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy a little bit) and VACCINATION SITE ERYTHEMA (red arm). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warmer than the normal part) and VACCINATION SITE URTICARIA (Red welt where I had the shot). At the time of the report, VACCINATION SITE WARMTH (Warmer than the normal part), VACCINATION SITE URTICARIA (Red welt where I had the shot) and VACCINATION SITE PAIN (Arm was sore) outcome was unknown and VACCINATION SITE PRURITUS (itchy a little bit) and VACCINATION SITE ERYTHEMA (red arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's arm is red and a little bit itchy, but they mentioned it is getting better now and is almost gone.  No treatment information provided.    Most recent FOLLOW-UP information incorporated above includes: On 18-Jan-2021: No specific follow-up information recorded.
I started experiencing symptoms 1/5/23 around 3 pm. My mouth started feeling relax , I was talking side ways. It has been very difficult to eat Ave drink. On 1/2/23 I experienced tough ashy on my cheeks , I had headaches as well
This spontaneous report has been received from an office manager referring to a 12 months old patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, and concurrent conditions was not reported. Concomitant therapies included sterile diluent. On an unknown date, the patients were vaccinated with Oka/Merck VARIVAX lot # N024567, expiration date of 07-SEP-2019, for prophylaxis (strength, dose, route and anatomical location were not provided). No adverse events reported. The vaccine was exposed to a temperature range of 39.5°F, during a time frame of 15 hours, which was called by a data logger. No previous temperature excursions were reported. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1802USA012116: US-009507513-1802USA011938.
Patient had shingles vaccination administered. The symptoms started around 30 hrs later with chills around 7pm.Also exp itching around nose,ears and lips are swollen. Seen by allergy doctor on 10/14/20 for itching but believes the shingles vaccination is causing the events.
Pt developed congestion and cough shortly after receiving the vaccine. She developed fever the following day and on 11/16 had a temp of 104. She also developed diarrhea, sore throat, and abdominal pain.